PDGFIR beta blockade bypasses resistance to combined MEK1/2-JAK2 inhibition in triple-negative breast cancer via intratumoral CD8+T-cells infiltration
Authors
Kalimutho, Murugan; Khanna, Kum Kum
Journal
CANCER RESEARCH
Pages
Volume
79
Date
1/07/2019
Grant ID
Funding Body
URL
http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1158/1538-7445.AM2019-LB-256